• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管反射测试可检测有症状和无症状的遗传性转甲状腺素蛋白淀粉样变性患者的自主神经功能障碍。

Cardiovascular reflex tests detect autonomic dysfunction in symptomatic and pre-symptomatic subjects with hereditary transthyretin amyloidosis.

作者信息

Guaraldi P, Rocchi C, Cani I, Gagliardi C, Longhi S, Baschieri F, Rinaldi R, Frezza E, D'Angelo R, Barletta G, Calandra-Buonaura G, Galiè N, Massa R, Cortelli P

机构信息

IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.

Neurology Unit, Department of Systems Medicine, Policlinico Tor Vergata, Rome, Italy.

出版信息

Clin Auton Res. 2023 Feb;33(1):15-22. doi: 10.1007/s10286-022-00921-x. Epub 2023 Jan 10.

DOI:10.1007/s10286-022-00921-x
PMID:36625973
Abstract

PURPOSE

Autonomic dysfunction is a distinctive but undervalued feature of hereditary transthyretin amyloidosis (ATTRv). It may predate the onset of polyneuropathy and cardiomyopathy, thereby providing crucial prognostic and therapeutic information. The objective of this study was to assess autonomic function by means of the standardized cardiovascular autonomic reflex tests (CRTs) in a cohort of subjects with genetically proven ATTRv from non-endemic areas who were in the symptomatic and pre-symptomatic stages.

METHODS

All subjects enrolled in this cross-sectional study had genetically proven ATTRv. They underwent the head-up tilt test, Valsalva manoeuvre, deep breathing test, cold face test and handgrip test while under continuous blood pressure and heart rate monitoring. Based on the results of the nerve conduction study, the subjects were divided into two groups: those with polyneuropathy (ATTRv-wPN) and those without polyneuropathy (ATTRv-woPN). Age- and sex-matched healthy controls (HC) were used for comparison.

RESULTS

Thirty-seven ATTRv subjects (19 with ATTRv-wPN, 18 with ATTRv-woPN) and 41 HC performed the CRTs. Of these 37 subjects with ATTRv, four (11%) presented neurogenic orthostatic hypotension the during head-up tilt test. Based on the results of the CRTs, autonomic dysfunction characterized by either sympathetic or parasympathetic impairment was detected in 37% and 63% of ATTRv-wPN subjects, respectively. Subjects with ATTRv-woPN presented a significant impairment of autonomic responses to the Valsalva manoeuvre compared to the HC (overshoot p = 0.004; Valsalva ratio p = 0.001).

CONCLUSION

Autonomic dysfunctions are frequent in subjects with ATTRv when investigated by means of standardized CRTs, and are also relevant in the pre-symptomatic stage. Cardiovagal functions are the primary functions affected, among others. This may be crucial in defining the proper diagnostic workout for early diagnosis and improving the likelihood of providing the patient with prompt administration of disease-modifying treatments.

摘要

目的

自主神经功能障碍是遗传性转甲状腺素蛋白淀粉样变性(ATTRv)的一个独特但未得到充分重视的特征。它可能早于多发性神经病和心肌病的发病,从而提供关键的预后和治疗信息。本研究的目的是通过标准化心血管自主反射测试(CRT)评估一组来自非流行地区、有基因证实的ATTRv且处于症状期和症状前期的受试者的自主神经功能。

方法

本横断面研究纳入的所有受试者均有基因证实的ATTRv。他们在持续监测血压和心率的情况下,接受了头高位倾斜试验、瓦尔萨尔瓦动作、深呼吸试验、冷脸试验和握力试验。根据神经传导研究结果,将受试者分为两组:患有多发性神经病的(ATTRv-wPN)和未患多发性神经病的(ATTRv-woPN)。采用年龄和性别匹配的健康对照(HC)进行比较。

结果

37名ATTRv受试者(19名ATTRv-wPN,18名ATTRv-woPN)和41名HC进行了CRT。在这37名ATTRv受试者中,有4名(11%)在头高位倾斜试验期间出现神经源性直立性低血压。根据CRT结果,在ATTRv-wPN受试者中,分别有37%和63%检测到以交感神经或副交感神经损伤为特征的自主神经功能障碍。与HC相比,ATTRv-woPN受试者对瓦尔萨尔瓦动作的自主反应存在显著损伤(过冲p = 0.004;瓦尔萨尔瓦比率p = 0.001)。

结论

通过标准化CRT进行研究时,自主神经功能障碍在ATTRv受试者中很常见,在症状前期也很明显。迷走心血管功能是受影响的主要功能之一。这对于确定早期诊断的正确诊断方法以及提高为患者及时给予疾病修饰治疗的可能性可能至关重要。

相似文献

1
Cardiovascular reflex tests detect autonomic dysfunction in symptomatic and pre-symptomatic subjects with hereditary transthyretin amyloidosis.心血管反射测试可检测有症状和无症状的遗传性转甲状腺素蛋白淀粉样变性患者的自主神经功能障碍。
Clin Auton Res. 2023 Feb;33(1):15-22. doi: 10.1007/s10286-022-00921-x. Epub 2023 Jan 10.
2
Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy.遗传性转甲状腺素蛋白淀粉样变性多发性神经病的坐骨神经磁共振神经成像和弥散张量成像。
J Neurol. 2023 Oct;270(10):4827-4840. doi: 10.1007/s00415-023-11813-z. Epub 2023 Jun 17.
3
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.一样又不一样?野生型转甲状腺素蛋白(ATTRwt)淀粉样变的神经表现。
Amyloid. 2022 Jun;29(2):92-101. doi: 10.1080/13506129.2021.2014448. Epub 2022 Jan 7.
4
Dysautonomia: A Forgotten Condition - Part 1.自主神经功能紊乱:一种被遗忘的疾病 - 第 1 部分。
Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420.
5
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.非地方性遗传性转甲状腺素蛋白淀粉样变性多发性神经病的真实世界结局:德国单转诊中心 20 年经验。
Amyloid. 2021 Jun;28(2):91-99. doi: 10.1080/13506129.2020.1855134. Epub 2020 Dec 7.
6
Altered connectivity of central autonomic network: effects of dysautonomia in hereditary transthyretin amyloidosis with polyneuropathy.中枢自主神经网络连接改变:遗传性转甲状腺素淀粉样变多发性神经病伴自主神经病变的影响。
Amyloid. 2024 Dec;31(4):257-265. doi: 10.1080/13506129.2024.2383450. Epub 2024 Jul 24.
7
Neurogenic orthostatic hypotension in early stage Parkinson's disease: New insights from the first 105 patients of the BoProPark study.早期帕金森病的神经原性直立性低血压:BoProPark 研究前 105 例患者的新见解。
Parkinsonism Relat Disord. 2021 Dec;93:12-18. doi: 10.1016/j.parkreldis.2021.11.002. Epub 2021 Nov 4.
8
Quantitative muscle ultrasound as a disease biomarker in hereditary transthyretin amyloidosis with polyneuropathy.定量肌肉超声作为遗传性转甲状腺素蛋白淀粉样变多发性神经病的疾病生物标志物。
Neurol Sci. 2024 Jul;45(7):3449-3459. doi: 10.1007/s10072-024-07340-y. Epub 2024 Jan 25.
9
Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy.间接治疗比较(ITC)评估 vutrisiran 和 tafamidis 治疗遗传性转甲状腺素淀粉样变多发性神经病的疗效。
Expert Opin Pharmacother. 2023 May-Aug;24(10):1205-1214. doi: 10.1080/14656566.2023.2215925. Epub 2023 May 26.
10
Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.非 Val30Met 遗传性转甲状腺素蛋白淀粉样变性中广泛存在的心脏和血管舒缩自主神经功能障碍。
Intern Med. 2018 Dec 1;57(23):3365-3370. doi: 10.2169/internalmedicine.1113-18. Epub 2018 Jul 6.

引用本文的文献

1
Examination of the autonomic nervous system at the bedside.床边自主神经系统检查。
Acta Neurol Belg. 2024 Dec 5. doi: 10.1007/s13760-024-02654-2.
2
Patisiran for the treatment of patients with p.Ile88Leu hereditary transthyretin amyloidosis: an Italian real-life experience.帕替拉韦用于治疗携带p.Ile88Leu遗传性转甲状腺素蛋白淀粉样变性的患者:意大利真实病例经验
Front Neurol. 2024 Jun 7;15:1415851. doi: 10.3389/fneur.2024.1415851. eCollection 2024.
3
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.

本文引用的文献

1
Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial.APOLLO 试验中基线多发性神经病严重程度对 patisiran 治疗效果的影响。
Amyloid. 2023 Mar;30(1):49-58. doi: 10.1080/13506129.2022.2118043. Epub 2022 Sep 18.
2
Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).转甲状腺素蛋白淀粉样变性心肌病患者自主神经功能障碍特征分析(THAOS)。
Amyloid. 2022 Sep;29(3):175-183. doi: 10.1080/13506129.2022.2043270. Epub 2022 Apr 22.
3
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
遗传性转甲状腺素蛋白淀粉样变性和 TTR 携带者的心血管自主神经衰竭是一种早期且进行性的疾病标志物。
Clin Auton Res. 2024 Jun;34(3):341-352. doi: 10.1007/s10286-024-01038-z. Epub 2024 May 20.
4
Early autonomic biomarkers in ATTRv carriers.转甲状腺素蛋白淀粉样变(ATTRv)携带者的早期自主神经生物标志物
Clin Auton Res. 2023 Feb;33(1):9-10. doi: 10.1007/s10286-023-00926-0. Epub 2023 Jan 31.
遗传性转甲状腺素蛋白淀粉样变性病诊断与管理的新方法。
J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):668-678. doi: 10.1136/jnnp-2021-327909. Epub 2022 Mar 7.
4
Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology.自主神经系统的电诊断评估:一份由美国自主神经学会、美国神经病学学会和国际临床神经生理联合会认可的共识声明。
Clin Neurophysiol. 2021 Feb;132(2):666-682. doi: 10.1016/j.clinph.2020.11.024. Epub 2020 Dec 22.
5
Hereditary transthyretin amyloidosis overview.遗传性转甲状腺素蛋白淀粉样变性概述。
Neurol Sci. 2022 Dec;43(Suppl 2):595-604. doi: 10.1007/s10072-020-04889-2. Epub 2020 Nov 14.
6
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.遗传性转甲状腺素蛋白淀粉样变性的直立性低血压:流行病学、诊断和治疗。
Clin Auton Res. 2019 Sep;29(Suppl 1):33-44. doi: 10.1007/s10286-019-00623-x. Epub 2019 Aug 26.
7
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review.他法米替尼治疗遗传性转甲状腺素蛋白淀粉样变相关自主神经病:综述。
Clin Auton Res. 2019 Sep;29(Suppl 1):19-24. doi: 10.1007/s10286-019-00625-9. Epub 2019 Aug 12.
8
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.依洛瑟那治疗遗传性转甲状腺素蛋白淀粉样变性病患者。
N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.
9
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.用于遗传性转甲状腺素蛋白淀粉样变性的 RNAi 治疗药物 Patisiran
N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.
10
Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).自主神经受累与遗传性转甲状腺素蛋白淀粉样变性(hATTR 淀粉样变性)。
Clin Auton Res. 2019 Apr;29(2):245-251. doi: 10.1007/s10286-018-0514-2. Epub 2018 Mar 6.